Patent Opposition Database

Hide annotations

No Annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): P000103425
Who filed: CILFA
Country: Argentina
Opposition type: Pre-Grant
Date: 14-01-2003
Patent type: Combination

Add an annotation

Where in the document

Click within the document, or manually enter the page number below

10 similar patent oppositions

CILFA opposition, carvedilol+hydrochlorothiazide, (P990105974)

Countries: Argentina Date: 2002
CILFA opposition, Nadifloxacin, (P990106490)

Countries: Argentina Date: 2002
CILFA opposition, Gamma-aminobutiric acid derivatives including gabapentin , pregabalin, baclofen, (P990102313)

Countries: Argentina Date: 2002
CILFA opposition, reverastrol + L-carnitine, (P990105115)

Countries: Argentina Date: 2002
CILFA opposition, antibióticos de quinolona, (P000103426)

Countries: Argentina Date: 2002
CILFA opposition, ranibizumab and bevacizumab, (AR092372A1)

Countries: Argentina Date: 2015
CILFA opposition, levothyroxine, (AR092151A1)

Countries: Argentina Date: 2015
CILFA opposition, estetrol/drospirenone, (AR114357A1)

Countries: Argentina Date: 2020
CILFA opposition, celecoxib, (P990106069)

Countries: Argentina Date: 2004
CILFA opposition, fexofenadine+cyclodextrins, (P990105185)

Countries: Argentina Date: 2002